AMRN

4:16 pm Amarin misses by $0.04, misses on revs

moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

Amarin Management Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – John F. Thero Thank you, everyone, for joining us today. With me on today’s call from Amarin are Steve Ketchum, our Vice President of R&D; Joe Kennedy, our Senior Vice President and General Counsel; Aaron … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is […]

Amarin Sues FDA Over Exclusivity for Fish Oil Pill

moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

4:16 pm Amarin misses by $0.04, misses on revs

moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations

[GlobeNewswire] – BEDMINSTER, N.J. and DUBLIN, Ireland — Amarin Corporation plc , a late stage biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

What Now For Amarin?

moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

Amarin’s Vascepa Gets 3-Year Exclusivity

moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]